Format

Send to

Choose Destination
Clin Endocrinol (Oxf). 2017 Aug;87(2):149-155. doi: 10.1111/cen.13356. Epub 2017 May 26.

A genetic risk score that includes common type 2 diabetes risk variants is associated with gestational diabetes.

Author information

1
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
2
Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN, USA.
3
Department of Internal Medicine, Meharry Medical College, Nashville, TN, USA.
4
Clinical Pharmacology Unit, Rambam Medical Center, Haifa, Israel.
5
Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
6
Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.

Abstract

OBJECTIVE:

Gestational diabetes (GDM) is characterized by maternal glucose intolerance that manifests during pregnancy. Because GDM resembles type 2 diabetes (T2DM), shared genetic predisposition is likely but has not been established. We tested the hypothesis that a genetic risk score (GRS) that included variants known to be associated with T2DM is associated with GDM.

STUDY DESIGN:

We conducted a case-control study using the Vanderbilt Medical Center biobank (BioVU) and calculated a simple-count GRS using 34 variants previously associated with T2DM or fasting glucose in the general population, or with GDM or glucose intolerance in pregnancy. We assessed the association of the GRS with GDM adjusting for maternal age, parity, and body mass index (BMI) and calculated the area under the curve for the receiver-operating characteristic curve (c-statistic).

STUDY POPULATION:

Among Caucasian women, we identified 458 cases of GDM and 1538 pregnant controls with normal glucose tolerance.

RESULTS:

Cases of GDM had a higher number of risk alleles compared to controls (38.9±4.0 vs 37.4±4.0 risk alleles, P=1.6×10-11 ). The GRS was significantly associated with GDM; the adjusted odds ratio associated with each additional risk allele was 1.10 (95% CI: 1.07-1.13, P=6×10-11 ). Clinical variables predicted the risk of GDM (c-statistic 0.67, 95% CI: 0.64-0.70), and adding the GRS modestly improved prediction (0.70, 95% CI: 0.67-0.73).

CONCLUSIONS:

Among Caucasian women, a GRS that included common T2DM genetic risk variants was associated with increased risk of GDM but showed limited utility in the identification of GDM cases.

KEYWORDS:

gestational diabetes; risk assessment; type 2 diabetes

PMID:
28429832
PMCID:
PMC5533106
DOI:
10.1111/cen.13356
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center